Impact of source position and transit time on HDR skin surface applicator dosimetry

Abstract

Purpose

Skin surface dosimetric discrepancies between measured and treatment planning system (TPS) predicted values were traced to source position sag inside the applicator and to source transit time. We quantified their dosimetric impact and propose corrections for clinical use.

Material and methods

We measured the dose profiles from the Varian Leipzig-style HDR skin applicator, using EBT3 film, photon diode, and optically stimulated luminescence dosimeter for three different GammaMed plus™ HDR afterloaders. The measured dose profiles at several depths were compared with BrachyVision Acuros™ calculated profiles. To assess the impact of the source sag, two different applicator orientations were considered. The dose contribution during source transit was assessed by comparing diode measurements using a HDR timer and an electrometer timer.

Results

Depth doses measured using the three dosimeters were in good agreement, but were consistently higher than the Acuros dose calculations. Measurements with the applicator face up were significantly (exceeding 10%) lower than those in the face down position, due to source sag inside the applicator. Based on the inverse square law, the effective source sag was evaluated to be about 0.5 mm from the planned position. The additional dose during source transit was evaluated to be about 2.8% for 30 seconds of treatment with a 40700 U (10 Ci) source.

Conclusion

With a very short source-to-surface distance, the small source sag inside the applicator has a significant dosimetric impact. This effect is unaccounted for in the vendor’s treatment planning template, and should be considered before the clinical use of the applicator. Further investigation of other applicators with large source lumen diameter may be warranted.